An investigative report calls attention to one-half of the problem with the new non-invasive prenatal screening tests for Down syndrome and other conditions. Continue Reading
Don’t abort based on MaterniT21
Or based on Harmony, verifi, Panorama, or any of the new prenatal blood-based tests for Down syndrome. Continue Reading
Three years on, what have we learned about non-invasive prenatal screening?
Three years ago, a new prenatal test for Down syndrome entered the market offering earlier, safer, and more accurate results. What have we learned about this new technology since then? Continue Reading
ACMG Posters: non-invasive prenatal screening still has false positives
Another roundup of research presented at this year's ACMG conference on prenatal testing for Down syndrome and other genetic conditions. Continue Reading
Webinar on new Down syndrome prenatal testing available now
On Tuesday, Dr. Brian Skotko and I presented a webinar on the new prenatal testing for Down syndrome and resources for support organizations. You can watch it now on-line. Continue Reading
Sequenom’s testing is not patentable: uses conventional techniques, not innovative
At the end of October, Judge Susan Illston of the Northern District federal court of California ruled that Sequenom's patent for its non-invasive testing was not patentable. Here's the surprising reasons why: Continue Reading
A confluence of conflicts of interests in Down syndrome prenatal testing
Yesterday, I shared Andrew Pollack's excellent column headlined "Conflict Potential Seen in Genetic Counselors." The report shared a confluence of conflicts of interests due to another recent development. Continue Reading
Noninvasive prenatal testing should be a secondary screen
The headline isn't my conclusion. Tellingly, it's the result arrived at by a researcher for one of the Non-Invasive Prenatal Screening (NIPS) labs. And, one of the labs that would prefer if the opposite were the case. Continue Reading
Recent Comments